Happy Nice Mall

A false trial was officially declared for the three-wire fraud against him. Elizabeth HolmesFounder of failed blood test startup Theranos, according to a federal court the file has been released Tuesday.

Mrs. Holmes, 37, found guilty Monday three numbers electronic fraud and a conspiracy to commit electronic fraud to lie to investors to raise money for his company. He was found not guilty on four charges of defrauding Theranos’ patients.

The three suspended numbers concerned the investments of three Theranos investors, who stated that Ms. Holmes had misled them. Jury members said on Monday that they could not agree on these decisions. a trial will be done next week to discuss these charges that prosecutors may choose to try again.

Mrs. Holmes — a Stanford University dropout and a one-time beginner who has turned into a Silicon Valley pariah — is also expected to receive a sentencing date at next week’s hearing for the counts for which he was convicted. Each electronic fraud count carries a maximum prison sentence of 20 years. Ms. Holmes can appeal her conviction, sentence, or both.

Hanging counts came after a while jury of eight men and four women spent 50 hours over seven days coming to a decision. On Monday, they told Edward J. Davila, Judge of the United States District Court for the Northern California District, who presided over the case, twice. locked up Three charges against Miss Holmes. The other eight counts were given instead of decisions.

The three suspended are related to investors Alan Eisenman, Chris Lucas of Black Diamond Ventures and Bryan Tolbert of Hall Group. Each has invested in Theranos, and some of its transactions have formed the basis of three electronic scams.

Mr. Eisenman stated that he believed Ms. Holmes was withholding information from him. Mr. Lucas said that the main source of information on Theranos was Mrs. Holmes. Mr Tolbert said in court that he supports the understanding that Theranos’ technology is ready for deployment.

Due diligence of investors – and lack of them – was the main theme during the case, which was seen as a verdict against Silicon Valley’s culture of hype and hustle and bustle.

In total, Theranos has raised $945 million from investors over its lifetime. These investments were wiped out after the company’s blood tests, which were supposed to be able to distinguish various ailments from a few drops of patient’s blood, proved ineffective.